In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)
Gastrointestinal adverse events were common, with nausea and decreased appetite reported more frequently in the semaglutide group
Below is a breakdown of typical doses for each semaglutide medication, along with instructions on how and when they may be adjusted
Swirling is a much gentler method that allows the molecules to hydrate and dissolve without breaking
Sprout says your initial rate stays locked even if your dose increases
Obesity is a major risk factor for high blood pressure, so by promoting weight loss, semaglutide often leads to a meaningful drop in blood pressure, including for people whose readings remain high despite taking blood pressure medications